ClariVest Asset Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-89,642
| Closed | -$454K | – | 745 |
|
|
2022
Q4 | $454K | Sell |
89,642
-266
| -0.3% | -$1.35K | 0.02% | 391 |
|
|
2022
Q3 | $447K | Sell |
89,908
-243
| -0.3% | -$1.21K | 0.02% | 374 |
|
|
2022
Q2 | $335K | Buy |
90,151
+36,424
| +68% | +$135K | 0.01% | 421 |
|
|
2022
Q1 | $302K | Buy |
53,727
+14,666
| +38% | +$82.4K | 0.01% | 438 |
|
|
2021
Q4 | $237K | Sell |
39,061
-167,271
| -81% | -$1.01M | 0.01% | 474 |
|
|
2021
Q3 | $2.01M | Sell |
206,332
-10,093
| -5% | -$98.3K | 0.07% | 233 |
|
|
2021
Q2 | $3.09M | Buy |
+216,425
| New | +$3.09M | 0.1% | 178 |
|